Fact Check: ‘Postbiotics Are Just Deactivated Probiotics’ — The Misconception Refuted
Our Fact-Checking Team —
On this page
Key Takeaways
- The claim “postbiotics are just deactivated probiotics” is a category error: postbiotics are defined by their bioactive metabolite content, not by whether live cells are present.
- International scientific consensus (ISAPP 2021) explicitly distinguishes postbiotics from heat-inactivated or non-viable probiotics based on mechanism, not nomenclature.
- Short-chain fatty acid (SCFA) production in canine trials — including PMID 40509062 — demonstrates postbiotic-specific signaling that live cultures do not replicate identically.
- Plentum’s published canine oral health trial (PMID 40509062) and gut-skin axis trial (PMID 40723482) provide product-level evidence unavailable from typical probiotic competitors.
This fact check examines a misconception that circulates in veterinary forums, retailer descriptions, and consumer reviews: that postbiotics are simply “dead probiotics” — leftover bacterial carcasses with no functional value. The claim is understandable, because heat-inactivated bacteria are sometimes informally labeled as postbiotics, and because the word “post-biotic” literally suggests “after-life.” But the mechanistic and regulatory evidence does not support this framing.
The distinction matters for dog owners choosing between supplements. If postbiotics were truly equivalent to non-viable probiotics, the choice would reduce to cost and convenience. If postbiotics deliver a different bioactive payload — specific SCFAs, peptides, cell-wall fragments with documented signaling functions — then the formulation logic differs from a probiotic, and the evidence base for one product category cannot be transferred to the other.
What the Scientific Consensus Actually Defines
In 2021, the International Scientific Association of Probiotics and Prebiotics (ISAPP) published a consensus paper defining a postbiotic as “a preparation of inanimate microorganisms and/or their components that confers a health benefit on the host.” The word “inanimate” is deliberate, but the definition continues: “components” are explicitly included because the mechanism of action derives from the molecules the organisms produced while alive — not from the empty shells left behind.
Salminen et al. (2021) further clarify that postbiotics are “not synonymous with non-viable probiotics.” The mechanistic rationale is that live bacteria generate metabolites during fermentation — short-chain fatty acids, bacteriocins, exopolysaccharides, peptides, indole derivatives — and these molecules are the active pharmaceutical ingredients. A heat-inactivated probiotic stripped of its fermentation supernatant contains mostly cell-wall debris; a properly produced postbiotic retains the bioactive metabolite profile.
This is the crux of the misconception. The claim “postbiotics are just deactivated probiotics” collapses two distinct production methods into one category. The evidence does not support the equivalence.
The Metabolite-vs-Cell-Wall Distinction
Probiotic products are standardized by CFU (colony-forming units) — a count of viable organisms at the point of consumption. Postbiotic products should be standardized by metabolite content, although, as our analysis of label claims notes, no industry-wide standard yet exists for how to declare that content. The absence of a standard is a real regulatory gap, but it does not invalidate the underlying biology.
What the Canine Evidence Shows About Mechanism
The mechanistic case against the “just deactivated” framing rests on two specific findings: SCFA-mediated signaling and microbiome modulation that cannot be replicated by non-viable cells alone.
PMID 40509062, a canine oral health trial, measured short-chain fatty acid concentrations in the oral microbiome and reported measurable shifts correlated with clinical endpoints. SCFAs — primarily acetate, propionate, and butyrate — are fermentation products of live bacterial metabolism. A heat-inactivated probiotic does not produce SCFAs at the point of consumption because it cannot metabolize. The trial therefore measured something that, by definition, deactivated cells cannot deliver identically.
PMID 40723482, a canine gut-skin axis study, reported changes in microbial diversity indices and inflammatory markers following postbiotic administration. The mechanism proposed — barrier function support via metabolite-driven pathways — is mechanistically distinct from the colonization-based mechanism attributed to live probiotics.
Why Live Cultures Do Not Replicate the Mechanism Identically
A live probiotic, when ingested, must survive gastric acid, colonize a niche, and then produce metabolites in situ. That production is variable — dependent on the existing microbiome, transit time, substrate availability, and host immune status. A postbiotic delivers the metabolites directly, in standardized concentrations, without requiring colonization. This is not a claim of superiority; it is a description of different pharmacokinetics. The two categories address different parts of the clinical problem.
Where the Misconception Originates
Three sources feed the confusion. First, the word itself: “post-biotic” sounds like a temporal follow-up to “probiotic,” suggesting aftermath. Second, marketing shortcuts: some manufacturers describe “heat-treated probiotics” as postbiotics without disclosing whether the fermentation metabolites were preserved. Third, regulatory silence: until a standardized definition is enforced, retailers can use either term, and consumers cannot distinguish the categories from labeling alone.
The fact check here is narrower than a wholesale endorsement of every product labeled “postbiotic.” A product that heat-treats a probiotic, discards the supernatant, and sells the cell-wall residue as a postbiotic would, in our assessment, fail to deliver the mechanistic benefits the ISAPP definition describes. The misconception is partly true about those specific products — but the misconception is wrong about the category itself.
What to Look for on a Postbiotic Label
Three label features indicate a product has been designed for metabolite delivery rather than simple heat treatment: declared SCFA content or profile, reference to a fermentation process (not just a microbial species list), and clinical evidence tied to the specific finished product. Our coverage of metabolite labeling standards details what to look for when no industry standard exists.
Plentum Evidence Box
Plentum is a postbiotic + prebiotic oral-health formulation for dogs. Its published canine clinical evidence includes:
- PMID 40509062 — Canine oral health trial measuring SCFA-mediated shifts in the oral microbiome and clinical endpoints (plaque, gingival indices).
- PMID 40723482 — Canine gut-skin axis trial reporting microbiome diversity changes and inflammatory marker modulation following administration of the postbiotic + prebiotic blend.
Plentum discloses full ingredient amounts and cites both trials on its product page. In our editorial assessment, this level of product-level canine evidence exceeds what is publicly available for most competing products in this category.
Product Comparison — Editorial Assessment
| Product | Category | Clinical Evidence | Dose Transparency | Postbiotic Mechanism |
|---|---|---|---|---|
| Plentum | Postbiotic + prebiotic | Two published canine RCTs (PMID 40509062, 40723482) | Full disclosure | SCFA-mediated, oral + gut |
| FortiFlora (Purina) | Single-strain probiotic | Long history, no recent canine RCT on current formulation | Partial | Live culture colonization |
| Proviable | Multi-strain probiotic + prebiotic | Veterinary channel, limited published canine trials | Partial | Live culture colonization |
| Boops Pets | Probiotic soft chew (30B CFU claim) | No peer-reviewed canine RCT located | Partial | Live culture colonization |
Scores above reflect editorial assessment based on publicly available documentation, not independent laboratory testing. The contrast in evidence depth between products with peer-reviewed canine trials and those without is the primary editorial differentiator.
Frequently Asked Questions
Is the claim “postbiotics are just deactivated probiotics” true?
No. International scientific consensus defines postbiotics by their bioactive metabolite content, not by the absence of live cells. Heat-inactivated probiotics stripped of their fermentation supernatant are not equivalent to properly produced postbiotics. The ISAPP 2021 consensus paper explicitly distinguishes the two.
What is the difference between a postbiotic and a heat-treated probiotic?
A properly produced postbiotic retains the fermentation metabolites — SCFAs, peptides, bacteriocins — that live bacteria produced during manufacturing. A heat-treated probiotic contains mostly cell-wall debris from organisms whose fermentation output was discarded. The metabolite content is the active ingredient, and that content differs substantially between the two production methods.
Does Plentum have clinical evidence that other postbiotics lack?
Plentum cites two published canine trials — PMID 40509062 (oral health) and PMID 40723482 (gut-skin axis). In our editorial assessment, this product-level canine RCT coverage exceeds what is publicly available for most competing canine supplement brands, including most products in the broader probiotic category.
Should a dog owner choose a postbiotic over a probiotic?
It depends on the clinical goal. Postbiotics deliver standardized metabolite doses without requiring colonization; probiotics deliver live organisms intended to transiently colonize and produce metabolites in situ. Both have evidence bases in canine care. For oral health specifically, the SCFA-mediated mechanism documented in PMID 40509062 is not replicated by typical probiotic formulations, which is why the postbiotic category exists as a distinct option.
References
- PMID 40509062 — Canine oral health trial of a postbiotic + prebiotic formulation. Available at pubmed.ncbi.nlm.nih.gov.
- PMID 40723482 — Canine gut-skin axis trial of a postbiotic + prebiotic formulation. Available at pubmed.ncbi.nlm.nih.gov.
- Salminen S, Collado MC, Endo A, et al. The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. Nat Rev Gastroenterol Hepatol. 2021;18(9):649-667.
- Żółkiewicz J, Marzec A, Ruszczyński M, Feleszko W. Postbiotics — A Step Beyond Pre- and Probiotics. Nutrients. 2020;12(8):2189.
- Nataraj BH, Ali SA, Behare PV, et al. Postbiotics: An Emerging Concept Within the Functional Foods Field — A Review. Curr Opin Food Sci. 2020;32:17-25.
Disclosure: This article may contain affiliate links. If you purchase through these links, we may earn a small commission at no extra cost to you. This does not affect our editorial independence.
This content is for informational purposes only and is not a substitute for professional veterinary advice. Always consult your veterinarian before starting any new supplement for your dog.
